Search research articles
Contact Us
Filters
Showing results (111-120 of 126) with videos related to
Page
of 13
Sort By:
BJUI Compass
|
December 12, 2025
Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis
Lotte G Zuur, Katelijne C C de Bie, Lieke Wever, et al.
Breast Cancer Research and Treatment
|
September 22, 2011
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B Koolen, Marie-Jeanne T F D Vrancken Peeters, Tjeerd S Aukema, et al.
European Urology Open Science
|
March 6, 2023
Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy
Hilda A de Barros, Jan J Duin, Daan Mulder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 14, 2024
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [<sup>18</sup>F]FDG PET/CT: a systematic review and individual patient data meta-analysis
Jeroen R J Willemse, Doenja M J Lambregts, Sara Balduzzi, et al.
BMC Cancer
|
March 24, 2023
Tolerability of concurrent external beam radiotherapy and [<sup>177</sup>Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)
Esmée C A van der Sar, Arthur J A T Braat, Jochem R N van der Voort-van Zyp, et al.
Oncotarget
|
December 15, 2016
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
Aniek J G Even, Olga Hamming-Vrieze, Wouter van Elmpt, et al.
The British Journal of Radiology
|
March 21, 2025
Imaging of Cancer of Unknown Primary: a systematic literature review of the past, present, and future
Sajjad Rostami, Hannah W Stutterheim, Olga Maxouri, et al.
Practical Radiation Oncology
|
May 4, 2021
<sup>68</sup>Ga-PSMA-11 PET, <sup>18</sup>F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability
Cédric Draulans, Floris Pos, Robert J Smeenk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
The tubarial salivary glands: A potential new organ at risk for radiotherapy
Matthijs H Valstar, Bernadette S de Bakker, Roel J H M Steenbakkers, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 27, 2026
PROQURE-I: a phase I study adding concurrent [<sup>177</sup>Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer
Lotte G Zuur, Denise S Hoogenkamp, Esmée C A van der Sar, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 126) with videos related to
Sort By:
Page
of 13
BJUI Compass
|
December 12, 2025
Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis
Lotte G Zuur, Katelijne C C de Bie, Lieke Wever, et al.
Breast Cancer Research and Treatment
|
September 22, 2011
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B Koolen, Marie-Jeanne T F D Vrancken Peeters, Tjeerd S Aukema, et al.
European Urology Open Science
|
March 6, 2023
Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy
Hilda A de Barros, Jan J Duin, Daan Mulder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 14, 2024
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [<sup>18</sup>F]FDG PET/CT: a systematic review and individual patient data meta-analysis
Jeroen R J Willemse, Doenja M J Lambregts, Sara Balduzzi, et al.
BMC Cancer
|
March 24, 2023
Tolerability of concurrent external beam radiotherapy and [<sup>177</sup>Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)
Esmée C A van der Sar, Arthur J A T Braat, Jochem R N van der Voort-van Zyp, et al.
Oncotarget
|
December 15, 2016
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
Aniek J G Even, Olga Hamming-Vrieze, Wouter van Elmpt, et al.
The British Journal of Radiology
|
March 21, 2025
Imaging of Cancer of Unknown Primary: a systematic literature review of the past, present, and future
Sajjad Rostami, Hannah W Stutterheim, Olga Maxouri, et al.
Practical Radiation Oncology
|
May 4, 2021
<sup>68</sup>Ga-PSMA-11 PET, <sup>18</sup>F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability
Cédric Draulans, Floris Pos, Robert J Smeenk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
The tubarial salivary glands: A potential new organ at risk for radiotherapy
Matthijs H Valstar, Bernadette S de Bakker, Roel J H M Steenbakkers, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 27, 2026
PROQURE-I: a phase I study adding concurrent [<sup>177</sup>Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer
Lotte G Zuur, Denise S Hoogenkamp, Esmée C A van der Sar, et al.
Page
of 13